Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.
Jimenez J, Gwillim EC, Kosche C, Figueiredo A, Rauck C, Rangel SM, Choi J, West DP, Nardone B, Lacouture ME. Jimenez J, et al. Among authors: rangel sm. J Am Acad Dermatol. 2020 Sep;83(3):955-957. doi: 10.1016/j.jaad.2020.01.059. Epub 2020 Jan 31. J Am Acad Dermatol. 2020. PMID: 32014533 Free PMC article. No abstract available.
Malignant melanoma associated with chronic once-daily aspirin exposure in males: A large, single-center, urban, US patient population cohort study from the "Research on Adverse Drug events And Report" (RADAR) project.
Orrell KA, Cices AD, Guido N, Majewski S, Ibler E, Huynh T, Rangel SM, Laumann AE, Martini MC, Rademaker AW, West DP, Nardone B. Orrell KA, et al. Among authors: rangel sm. J Am Acad Dermatol. 2018 Oct;79(4):762-764. doi: 10.1016/j.jaad.2018.03.031. Epub 2018 Mar 27. J Am Acad Dermatol. 2018. PMID: 29601934 No abstract available.
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease.
Brunner PM, He H, Pavel AB, Czarnowicki T, Lefferdink R, Erickson T, Canter T, Puar N, Rangel SM, Malik K, Estrada Y, Krueger JG, Guttman-Yassky E, Paller AS. Brunner PM, et al. Among authors: rangel sm. J Am Acad Dermatol. 2019 Aug;81(2):510-519. doi: 10.1016/j.jaad.2019.04.036. Epub 2019 Apr 19. J Am Acad Dermatol. 2019. PMID: 31009665
Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP, Kelm RC, Orrell KA, Patel KR, Singam V, Ali Y, Rastogi S, Yousif R, Rangel SM, West DP, Nardone B. Vakharia PP, et al. Among authors: rangel sm. Int J Dermatol. 2020 Apr;59(4):463-468. doi: 10.1111/ijd.14781. Epub 2020 Jan 23. Int J Dermatol. 2020. PMID: 31971260
Product of Investigator Global Assessment and Body Surface Area (IGAxBSA): A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children.
Suh TP, Ramachandran D, Patel V, Jackson KL, Rangel SM, Fishbein AB, Paller AS. Suh TP, et al. Among authors: rangel sm. J Am Acad Dermatol. 2020 May;82(5):1187-1194. doi: 10.1016/j.jaad.2020.01.023. Epub 2020 Jan 21. J Am Acad Dermatol. 2020. PMID: 31972257 Free PMC article.
53 results